Concepedia

Publication | Open Access

Multi tyrosine kinase inhibitor dasatinib as novel cause of severe pre-capillary pulmonary hypertension?

DOIFull Paper Access

59

Citations

10

References

2011

Year

Jan K. Hennigs, Gunhild Keller, Hans Jörg Baumann, Friedemann Honecker, Stefan Kluge, Carsten Bokemeyer, Tim H. Brümmendorf, Hans Klose
BMC Pulmonary Medicine

Abstract

We therefore recommend systematic screening of dasatinib-treated patients for pulmonary hypertension and subsequent collection of haemodynamic data.

References

YearCitations

Page 1